United States: Supreme Court Limits Availability of State Action Immunity from Federal Antitrust Liability

The Supreme Court decision in FTC v. Phoebe Putney Health System, Inc., makes clear that state action immunity from federal antitrust laws is disfavored, and local governmental, quasi-public and private entities can only qualify for the immunity under certain specific conditions.

In a unanimous decision issued on February 19, 2013, the Supreme Court of the United States limited availability of state action immunity from federal antitrust laws for local governmental entities.  In FTC v. Phoebe Putney Health System, Inc., the Supreme Court ruled that local governmental authorities are not immune from federal antitrust laws when engaging in anticompetitive conduct, notwithstanding a grant of general powers by a state.  If the state did not "clearly articulate and affirmatively express" a policy to displace competition, then state action immunity will not apply to shield the conduct from antitrust liability.  To qualify for state action immunity, the local governmental entity's conduct must instead be the "inherent, logical, or ordinary" result of exercising a state's delegated authority.  Moreover, the Supreme Court cautioned that even if a state authorizes some forms of anticompetitive conduct, such authorization does not establish that the state has affirmatively blessed other forms of anticompetitive conduct.  The Supreme Court's ruling means that local governmental and quasi-public entities must re-examine their enabling legislation to determine whether and to what extent state legislation shields their conduct from federal antitrust liability.  Similarly, private entities should carefully review any legislation that forms the basis for their claim of state action immunity.

The Phoebe Putney decision involved the Federal Trade Commission's (FTC's) challenge of a Georgia governmental hospital authority's purchase of a competing hospital.  Georgia's Hospital Authorities Law authorizes political subdivisions (i.e., counties and municipalities) to create special-purpose public entities called hospital authorities, and grants them 27 powers upon creation.  Included in this general grant of powers is the power to "acquire by purchase, lease, or otherwise and to operate projects." 

In 1941, pursuant to this law, the city of Albany and the county of Dougherty created the Hospital Authority of Albany-Dougherty County (Authority), and the Authority subsequently acquired Phoebe Putney Memorial Hospital (Memorial).  In 1990, the Authority created two nonprofit corporations to manage Memorial: Phoebe Putney Health System, Inc., (PPHS) and its subsidiary, Phoebe Putney Memorial Hospital, Inc. (PPMH).  The Authority then leased Memorial to PPMH and gave PPMH the exclusive authority to operate Memorial.  In 2010, PPHS entered discussions with HCA, Inc., to acquire Palmyra Medical Center.  Memorial and Palmyra are the only two hospitals located in Dougherty County, Georgia.  Together, they accounted for 86 percent of the market for acute-care hospital services provided to commercial health plans in the six counties surrounding the city of Albany.  PPHS and HCA agreed to a plan under which the Authority would purchase Palmyra with PPHS funds, then lease Palmyra to PPHS in the same way the Authority leased Memorial to PPMH. 

The FTC issued an administrative complaint on April 20, 2011, alleging that the transaction would create a monopoly and substantially reduce competition in the market for acute-care hospital services.  The FTC, along with the State of Georgia, also filed suit to enjoin the transaction pending the FTC's administrative trial on the merits. 

The U.S. District Court for the Middle District of Georgia denied the FTC's motion for preliminary injunction and granted respondents' motion to dismiss, holding that the respondents were immune from antitrust liability under the state action doctrine.  The U.S. Court of Appeals for the 11th Circuit affirmed that state action immunity applied to shield the transaction from antitrust liability.  The 11th Circuit explained that the Hospital Authorities Law contemplated the anticompetitive conduct at issue.  The 11th Circuit also noted the "impressive breadth" of powers the law delegated to hospital authorities, specifically the power to acquire and lease projects.  The 11th Circuit reasoned that the Georgia legislature must have anticipated that the broad powers given to hospital authorities would produce anticompetitive effects.  After issuing its decision, the 11th Circuit dissolved the temporary injunction it had granted pending appeal, and the transaction closed.

The Supreme Court granted certiorari to determine whether the Georgia Hospital Authorities Law "clearly articulates and affirmatively expresses a state policy to permit acquisitions that substantially lessen competition."  (slip op. at 1)  In reversing the lower court decisions, the Supreme Court determined that the Georgia law does not include permission for hospital authorities to use their powers anticompetitively, and that, therefore, state action immunity does not apply. 

To begin its analysis, the Supreme Court first reiterated its earlier declaration in FTC v. Ticor Title Ins. Co. that "state-action immunity is disfavored."  (slip op. at 7 (citing 504 U.S. 621, 636) (1992))  Next, the Supreme Court explained that state action immunity will only apply if the challenged activities are undertaken pursuant to a "clearly articulated and affirmatively expressed state policy to displace competition."  (slip op. at 8 (citing Community Communications Co. v. Boulder, 455 U.S. 40, 52) (1982))  Following its prior decision in Boulder, the Supreme Court "rejected the proposition that the general grant of power to enact ordinances necessarily implies state authorization to exact specific anticompetitive ordinances because such an approach would wholly eviscerate the concepts of clear articulation and affirmative expression that our precedents require" (emphasis added).  (slip op. at 10)  The Supreme Court then explained that state action immunity applies only when the anticompetitive effect was the "foreseeable result of what the State authorized."  (slip op. at 8 (citing Hallie v. Eau Claire, 471 U.S. 34) (1985))  While conceding that the anticompetitive result need not be stated explicitly by the legislature to meet Hallie's foreseeability requirement, the Supreme Court cautioned that a state policy to displace federal antitrust law is sufficiently expressed only where "the displacement of competition was the inherent, logical, or ordinary result" of the act of delegation by the state legislature.  (slip op. at 11)

Applying these principles to the Hospital Authorities Law, the Supreme Court found that "there is no evidence the State affirmatively contemplated that hospital authorities would displace competition by consolidating hospital ownership."  (slip op. at 9)  The Supreme Court reasoned that while the Hospital Authorities Law permits the Authority to acquire hospitals, "it does not clearly articulate and affirmatively express a state policy empowering the Authority to make acquisitions of existing hospitals that will substantially lessen competition."  (slip op. at 10)  Turning to the lower court decisions, the Supreme Court criticized the 11th Circuit for too loosely applying the concepts of foreseeability.  (slip op. at 11)  The Supreme Court then noted that only a small subset of conduct permitted by the Hospital Authorities Law has the potential to negatively affect competition, and that even the power to acquire hospitals does not ordinarily produce anticompetitive effects.  (slip op. at 14)  The Supreme Court found that "nothing in the [Hospital Authorities Law] or any other provision of Georgia law clearly articulates a state policy to allow authorities to exercise their general corporate powers, including their acquisition power, without regard to negative effects on competition."  (slip op. at 16)  The Supreme Court went on to caution that "regulation of an industry, and even the authorization of discrete forms of anticompetitive conduct pursuant to a regulatory structure, does not establish that the State has affirmatively contemplated other forms of anticompetitive conduct that are only tangentially related."  (slip op. at 17)  In holding that Georgia did not clearly articulate and affirmatively express a state policy to allow hospital authorities to make acquisitions that would substantially lessen competition, the Supreme Court reversed the lower courts' decisions and remanded the case.  (slip op. 19)  Although the Supreme Court did not directly address how quasi-public and private entities might also qualify for state action immunity, those entities presumably must meet the Supreme Court's tightened standard as well.

The Supreme Court's decision represents a victory for the FTC and the U.S. Department of Justice Antitrust Division, which both have long sought to narrow the scope of state action immunity.  Going forward, local governmental, quasi-public and private entities will have a more difficult time asserting state action immunity as a defense to antitrust allegations where the underlying enabling legislation does not clearly contemplate potential competitive effects.  Local governmental, quasi-public and private entities should also re-examine enabling legislation and applicable state regulations to determine whether and to what degree their conduct might be protected from federal antitrust liability by the state action doctrine. 

Three immediate implications flow from the Supreme Court's decision in Phoebe Putney.  First, while it arguably narrows the scope of state action immunity, it does not mean that all government-owned hospitals will now be subject to potential antitrust liability for their conduct.  Many state statutes that authorize the formation and operation of local hospital authorities or districts contain language empowering them to engage in their delegated powers "irrespective of the competitive consequences" (or language to the same effect).  In those cases, state action immunity is likely to continue to insulate those entities from antitrust liability for their authorized actions.  Second, the fight over state action immunity is now likely to shift to the state legislatures, where parties on both sides of the issue will try to induce state legislatures to either "clearly articulate an intent to displace competition with regulation" or not.  Finally, the case serves as a reminder that all competitors, even government-owned and operated "competitors," should comply with the antitrust laws first, and invoke potential immunities or exemptions only as a last resort.

The McDermott Difference

McDermott's antitrust and competition lawyers have significant experience with these issues and can be a valuable resource to local governmental entities and private parties that need to re-evaluate whether state action immunity protects their conduct from federal antitrust liability.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

*** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.